Published: May 04, 2021
Total net sales of $2.9 billion up 20.4% versus prior year
GAAP diluted EPS from continuing operations of $1.16 versus prior-year GAAP diluted EPS from continuing operations of $0.91
Non-GAAP diluted EPS from continuing operations of $1.24 versus prior-year non-GAAP diluted EPS from continuing operations of $0.94
Reflecting strong first-quarter results, the Company raises guidance for 2021 non-GAAP diluted EPS from continuing operations to be at or above $3.70
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported record first-quarter financial results from continuing operations. Results from continuing operations exclude contributions from Henry Schein’s former Animal Health business, which was spun off in February 2019 to form a new publicly traded company, Covetrus (Nasdaq: CVET).